Clinical laboratory
Healthcare issues related to clinical laboratories;

H.R. 6102/S. 3404, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, provisions relating to FDA oversight of laboratory-developed tests;

Federal policy related to implementation of the Paycheck Protection Program and Healthcare Enhancement Act, Pub. L. 116-139, provisions relating to COVID-19 provider emergency funding, lab capacity funding, and funding of lab services to the uninsured;

Federal policy related to implementation of the Families First Coronavirus Response Act, Pub. L. 116-127, provisions relating to coverage of and funding for COVID-19 diagnostic tests;

Federal policy related to implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, Pub. L. 116-136, provisions relating to coverage and reimbursement of COVID-19 diagnostic tests, Medicare reimbursement for clinical laboratory tests, and emergency funding for COVID-19 related revenue losses and expenses not otherwise reimbursed;

H.R. 7059, the Coronavirus Provider Protection Act and H.R. 7528, the Get America Back to Work Act, provisions relating to limitation of liability for COVID-19 related services;

Section 307 of H.R. 8406, the Heroes Act, provisions relating to coverage of COVID-19 testing;

Federal policy relating to funding COVID-19 surveillance and transmission studies using next generation sequencing, including potential legislation;

Federal policy relating to anti-kickback requirements in Section 8122 of the Support for Patients and Communities Act, Pub. L. 115-271 (18 U.S.C. 220), including potential legislation as part of the Fiscal Year 2021 Commerce-Justice-Science appropriations bill and the Fiscal Year 2021 Labor-HHS appropriations bill; and

Federal policy relating to FDA oversight of pharmacogenetic tests, including potential legislation as part of the Fiscal Year 2021 Agriculture-FDA appropriations bill.
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
KELLEY DRYE & WARREN LLP
3050 K STREET, NW, SUITE 400, WASHINGTON, DC, 20007, US
DANA SCHNEEBERGER WOOD SCOTT MCGEE